Mariette Labots
Mariette Labots
Medical oncologist, VU University Medical Center, Amsterdam
Verified email at vumc.nl
Title
Cited by
Cited by
Year
Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance
KJ Gotink, HJ Broxterman, M Labots, RR De Haas, H Dekker, ...
Clinical Cancer Research 17 (23), 7337-7346, 2011
2632011
Pan-cancer whole-genome analyses of metastatic solid tumours
P Priestley, J Baber, MP Lolkema, N Steeghs, E de Bruijn, C Shale, ...
Nature 575 (7781), 210-216, 2019
2342019
The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies
L Angus, M Smid, SM Wilting, J van Riet, A Van Hoeck, L Nguyen, ...
Nature genetics 51 (10), 1450-1458, 2019
942019
Genomic landscape of metastatic colorectal cancer
JC Haan, M Labots, C Rausch, M Koopman, J Tol, LJM Mekenkamp, ...
Nature communications 5 (1), 1-12, 2014
592014
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs
DL van der Velden, LR Hoes, H Van Der Wijngaart, ...
Nature 574 (7776), 127-131, 2019
522019
Therapeutic drug monitoring to individualize the dosing of pazopanib: a pharmacokinetic feasibility study
D de Wit, NP van Erp, J den Hartigh, R Wolterbeek, ...
Therapeutic drug monitoring 37 (3), 331-338, 2015
522015
Evaluation of different phospho-tyrosine antibodies for label-free phosphoproteomics
JC van der Mijn, M Labots, SR Piersma, TV Pham, JC Knol, ...
Journal of proteomics 127, 259-263, 2015
452015
Strategies for kinome profiling in cancer and potential clinical applications: chemical proteomics and array-based methods
SR Piersma, M Labots, HMW Verheul, CR Jiménez
Analytical and bioanalytical chemistry 397 (8), 3163-3171, 2010
392010
Feasibility of label-free phosphoproteomics and application to base-line signaling of colorectal cancer cell lines
SR Piersma, JC Knol, I de Reus, M Labots, BK Sampadi, TV Pham, ...
Journal of proteomics 127, 247-258, 2015
362015
Molecular mechanisms and modulation of key pathways underlying the synergistic interaction of sorafenib with erlotinib in non-small-cell-lung cancer (NSCLC) cells
E Giovannetti, M Labots, H Dekker, E Galvani, JSW Lind, R Sciarrillo, ...
Current pharmaceutical design 19 (5), 927-939, 2013
332013
INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases
R Beekhof, C van Alphen, AA Henneman, JC Knol, TV Pham, F Rolfs, ...
Molecular systems biology 15 (4), e8250, 2019
302019
Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer
M Labots, KJ Gotink, H Dekker, K Azijli, JC Van Der Mijn, CM Huijts, ...
Experimental & molecular medicine 48 (12), e279-e279, 2016
202016
Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selection
M Labots, JC van der Mijn, R Beekhof, SR Piersma, RR de Goeij-de Haas, ...
Journal of proteomics 162, 99-107, 2017
182017
Mass spectrometry-based serum and plasma peptidome profiling for prediction of treatment outcome in patients with solid malignancies
M Labots, LM Schütte, JC van der Mijn, TV Pham, CR Jiménez, ...
The oncologist 19 (10), 1028, 2014
182014
Sex-and site-specific differences in colorectal cancer risk among people with type 2 diabetes
JA Overbeek, JG Kuiper, AAWA van der Heijden, M Labots, U Haug, ...
International journal of colorectal disease 34 (2), 269-276, 2019
162019
High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection
M Labots, TE Buffart, JC Haan, NCT van Grieken, M Tijssen, ...
Cellular oncology 37 (1), 41-52, 2014
162014
Phase I dose-escalation study of once weekly or once every two weeks administration of high-dose sunitinib in patients with refractory solid tumors
M Rovithi, SL Gerritse, RJ Honeywell, AJ Ten Tije, R Ruijter, GJ Peters, ...
Journal of Clinical Oncology 37 (5), 411, 2019
72019
Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome
M Labots, TV Pham, RJ Honeywell, JC Knol, R Beekhof, ...
Cancers 12 (2), 330, 2020
42020
The genomic landscape of 501 metastatic breast cancer patients
L Angus, SM Wilting, J van Riet, M Smid, TG Steenbruggen, ...
CANCER RESEARCH 79 (4), 2019
42019
Tumor, skin, and plasma concentrations of protein kinase inhibitors (PKIs) in patients with advanced cancer.
M Labots, M Neerincx, JC Van der Mijn, H Dekker, R Honeywell, ...
Journal of Clinical Oncology 31 (15_suppl), 11087-11087, 2013
42013
The system can't perform the operation now. Try again later.
Articles 1–20